Review Article - Neuropsychiatry (2017) Volume 7, Issue 1

Obstructive sleep apnea and retinal microvascular characteristics: a brief review

Corresponding Author:

Gen-Min Lin, MD, MPH
Department of Medicine
Hualien-Armed Forces General Hospital, No. 163, Jiali Rd.
Xincheng Township, Hualien 97144, Taiwan
Tel: +886-3826-0601
Fax: +886-3826-1370
E-mail: [email protected]

Abstract

Obstructive sleep apnea (OSA) causes intermittent nocturnal hypoxemia and is associated with obesity, diabetes, inflammation, endothelial dysfunction, and hypertension, possibly leading to micro- and macro-vascular disease. OSA has been associated with higher risk of clinical cardiovascular disease (CVD) independent of traditional risk factors and severity of atherosclerosis. Microvascular disease may be a potential mediator for the association of OSA with clinical CVD. However, evidence for the association between OSA and microvascular dysfunction is conflicting. Since the retinal microvasculature is structurally and functionally similar to microvasculature elsewhere in the body and can be directly visualized via ophthalmoscopy, several studies have assessed the relationship of OSA with retinal microvascular characteristics but shown inconsistent results. Notably, the multi-ethnic study of atherosclerosis (MESA) recently revealed that the associations of OSA severity with retinal microvascular signs may differ by sex. Moderate/severe OSA was associated with retinal vascular calibers in men, but not women.

Keywords

Cardiovascular disease, Obstructive sleep apnea, Retinal microvascular characteristics, Sex difference

Introduction

Obstructive sleep apnea (OSA) is a common syndrome with generalized effects on multiple systems in human body. OSA usually arises from airway closure at a supraglottic area when one sleep, causing absent or diminished airflow despite persistent respiratory effort, followed by hypoxia-induced arousal and termination of apnea [1]. Across the population, OSA is the major form of sleep apnea, affecting about 15 million American adults [2]. The prevalence of clinically relevant OSA in the general population increases with age [3] and is only 6% in women compared with 14% in men [4].

▪ OSA as a vascular risk factor and possible mechanisms involved

In previous studies, OSA has been associated with a wide range of clinical cardiovascular disease (CVD) including coronary heart disease, ischemic stroke, heart failure, and atrial fibrillation [3], independent of traditional risk factors [5].

The nature of OSA is cycles of deoxygenation and reoxygenation triggering production of reactive oxygen species and thus increasing oxidative stress leading to endothelial damage [6]. OSA causes sleep arousals accompanied with sympathetic bursts and persisting increase of sympathetic drive [7,8], which would contribute to increased vascular risk [9]. OSA also causes systemic inflammation which is associated with progression of atherosclerosis [10]. Nuclear factor kappa B, one of critical inflammation mediator, is found with significantly higher activation in patients with OSA than controls [11]. Several inflammatory markers, e.g. cytokines, matrix metalloproteinases, and acute phase proteins, endothelial adhesion molecules, are also positively associated with OSA [12]. OSA is also associated with endothelial dysfunction. OSA was shown to be associated with increased expression of adhesion molecules on monocytes and increased adhesion of monocytes to endothelium, while adhesion molecules were downregulated by continuous positive airway pressure [13], a recommended treatment for OSA. Another study also showed lower endothelial repair capacity in OSA, by measuring circulating endothelial progenitor cell levels [14]. A recent study found endocan, a novel surrogate marker for endothelial damage, was significantly associated with severity in AHI and endothelial dysfunction of OSA [15]. OSA is also associated with poor control of diabetes and hypertension which may contribute additional risk for vascular damage [5,16,17].

▪Microvascular disease: a potential mediator between OSA and clinical CVD

Microvascular disease may be a potential mediator for the association between OSA and clinical CVD. However, current evidence for the association between OSA and microvascular disease is conflicting.

Since most previous studies approached the microvasculature in target organs indirectly by renal microalbuminuria measurements, cardiac perfusion scan, and cerebral imaging studies, the results may not be convinced in the absence of pathological approval. The retinal microvasculature is structurally and functionally similar to microvasculature elsewhere in the body and can be directly visualized via ophthalmoscopy [18]. Several studies have assessed the relationship of retinal microvascular signs with multiple CVD risk factors. Retinal arteriolar narrowing is strongly related to age and hypertension [19], while retinal venular widening is related to cigarette smoking, metabolic abnormalities, inflammation, and atherosclerosis [20,21]. Retinopathy signs, specifically microaneurysms, hemorrhages, and cotton wool spots found in patients with diabetes, are also prevalent in the general population (5-10%), and may be related to age, obesity, hyperglycemia, elevated blood pressure, and inflammation [21].

Because there lacks substantial evidence for the relationship of OSA with microvascular characteristics, we made a brief review of literatures regarding the topic where microvasculature were evaluated by indirect methods and direct fundus photography (Table 1).

Table 1: Obstructive Sleep Apnea and Microvascular Dysfunction in Kidney, Brain, and Heart.

There were a number of studies regarding the relationship between OSA and microvascular dysfunction in kidney in the Asian and Caucasian populations with or without hypertension [22-29]. Renal microvascular disease was usually evaluated by single dipstick or 24-hour urinary analysis for microalbuminuria, proteinuria, albumin-to-creatinine ratio, and serum cystatin measurements. In general, intermittent hypoxemia marked by oxygen desaturation index (<3%) greater than 5 times per hour, minimal oxygenation, or duration of oxygen saturation <90% were consistently associated with renal microvascular injury [22,24-26,28,29]. In contrast, the results for the association of severity of OSA defined by apnea-hypopnea index (AHI) or respiratory disturbance index (RDI) with renal microvascular injury were conflicting [22-24,27-29]. Some studies revealed that there was an association but some showed null association. In addition, the Osteoporotic Fractures in Men (MrOS) study and the study by Ting et al. demonstrated that older age may be a moderator for the AHI or RDI association [24-26,28].

Similarly, several studies regarding the relationship of OSA with cerebral and brain stem small vessel disease in the Asian and Caucasian subjects with or without cerebrovascular disease were performed [30-38]. Cerebral small vessel disease was represented by white matter changes or lacunar infarcts in brain magnetic resonance imaging (MRI) or computed tomography studies. There were no consistent results for a positive relationship between moderate to severe OSA classified by AHI or RDI and cerebral small vessel disease [30-38]. The results were also uncertain for the association of intermittent hypoxemia with cerebral small vessel disease [31]. In addition, one study by Ding et al. showed that the arousal index might be inversely associated with brain stem white matter changes in MRI [32].

With regard to the association between OSA and cardiac microvascular dysfunction, some reports were conducted in the Asian and Caucasian patients with or without acute myocardial infarction [39-42]. Microvascular dysfunction was evaluated by myocardial perfusion imaging: contrast echocardiography, Doppler coronary flow velocity reserve, or single photon emission computed tomography. The results regarding the association between moderate to severe OSA defined by AHI and myocardial microvascular dysfunction in patients with acute myocardial infarction following primary percutaneous coronary intervention were controversy as well [42,43]. This finding might be confounded by the production of lipid microemboli from atheroma plaque rupture [44]. In addition, one case series by Orea-Tejeda et al. showed that myocardial perfusion defects appear to occur with highest frequency and severity during nighttime sleep rather than daytime awake [40] (Table 2).

Table 2: OSA and Retinal Microvascular Characteristics.

Through the ocular fundus, retinal blood vessels can be visualized easily and noninvasively. Retinal vessels, which share similar embryological origin, anatomical features and physiological characteristics with cerebral and coronary vasculatures, provide an opportunity to view microvascular abnormalities and reflect the status of CVD [45-47].

As above review, there is emerging evidence showing that OSA is a risk factor of CVD. Moreover, hypoxia and elevated sympathetic tone resulted from OSA can lead to vascular endothelium dysfunction and abnormal autoregulation. Therefore studies were designed to investigate the relationship between OSA and retinal microvascular changes. Boland et al. first used arteriolar-to-venular ratio (AVR) to quantitatively prescribe retinal arteriolar narrowing, and found an increase in respiratory disturbance index (RDI) from 0 to 10 was associated with a decrease of AVR [48]. The overall prevalence of retinal microvascular abnormalities, including microaneurysms, hemorrhages, soft or hard exudates, macular edema, intraretinal microvascular abnormalities, venous beading, new vessels at the disc or elsewhere, vitreous hemorrhage, disc swelling, or laser photocoagulation scars, was 6.6%. Except microaneurysms, the prevalence of which was doubled in the upper 2 versus the lower 2 RDI quartiles, further multivariable analysis showed that there was no clear association between other retinal microvascular abnormalities and the severity of OSA (i.e. RDI or hypoxemia) [48].

A low retinal AVR may be contributed from smaller retinal arteriolar caliber or a larger retinal venular diameter. Smaller retinal arteriolar diameters were related to increasing blood pressure [49,50], and were not associated with the markers of atherosclerosis except increased carotid intima–media thickness [49]. Larger venular diameters were associated with several markers of atherosclerosis [49], inflammation [49,50] and dyslipidemia [49-51]. With regard to different pathogenesis in the changes of retinal arterioles and venules, Shankar et al. investigated the association between OSA and retinal arteriolar and venular diameters separately [52]. Higher AHI was positively associated with retinal venular widening but not with arteriolar narrowing, and was independent of age, sex, body mass index, diabetes, and serum lipid levels [52]. These findings suggest that the microvascular dysfunction of OSA might be related to atherosclerosis inflammation, and factors that are associated with widening of retinal venules. OSA is highly associated with diabetes mellitus which in turn contributes to retinopathy. OSA is associated with an increased prevalence of metabolic syndrome and type 2 diabetes [53-57], and 40% to 80% of patients with type 2 diabetes have OSA [58-60]. Current evidence suggest that hypoxia and inflammatory process leading to endothelial dysfunction play a pivotal role in the cardiovascular pathophysiology of OSA [61-64], which may also increase the development and progression of complications related to diabetes [65-69]. Diabetic patients with OSA were at higher risk of developing diabetic retinopathy and maculopathy than those without OSA [65-67]. The incidence of proliferative diabetic retinopathy was higher in diabetes with OSA [67]. However, AHI level did not predict the severity of diabetic retinopathy or maculopathy [67]. Minimal oxygen saturation during sleep is an independent predictive factor of the presence of diabetic retinopathy, especially maculopathy [68,69], suggesting that it was the severity of hypoxemia during sleep that correlated to the development of retinopathy (Table 3).

Table 3: Sex differences in the Association of OSA With Retinal Microvascular Characteristics and Clinical CVD.

The nature course of OSA differs between men and women. Men are more prone to be affected by OSA than women. Clinical manifestations of OSA also differ by sex, for example apnea/ hypopnea are more severe among men with OSA, while snoring and daytime sleepiness seems similarly frequent between men and women [70,71]. Sex differences in sleep architecture are found both in OSA patients and the unaffected controls [72]. Fat distribution, upper airway anatomy, arousal response and sex hormones are possible factors for the sex differences in OSA [72].

Recently, the sex-specific association between OSA and retinal microvascular characteristics has been investigated in two cohorts at the multiethnic study of atherosclerosis (MESA) visits 2 and 5 respectively. Chew et al. [73] revealed that self-reported physician-diagnosed sleep apnea (PDSA) obtained from a sleep questionnaire was associated with retinal arteriolar narrowing in women (regression coefficient [β] −5.76; 95 % confidence interval (CI): −8.51- −3.02) but not in men and there was no association between PDSA and specific retinopathies at MESA visit 2. In contrast, Lin et al. [74], showed that moderate/severe OSA diagnosed by an objective polysomnography was associated with retinal arteriolar narrowing and venular widening in men (Odds ratio (OR): 1.65, 95% CI: 1.00-2.71 and OR: 1.80, 95% CI: 1.07-3.04, respectively) but not in women (OR: 1.10, 95% CI: 0.67-1.81 and OR: 0.91, 95% CI: 0.58-1.43). They also found severe OSA was associated with retinal microaneurysm, in women (OR: 3.22, 95% CI: 1.16-8.97) but not in men (OR: 0.59, 95% CI: 0.27-1.30) in an older cohort at MESA visit 5. These contradictory results might be attributed to different diagnostic tools and measurements of OSA. Although PDSA represented more severe OSA [75], the result of the PDSA association might be erroneous for the contamination of mild OSA in the unaffected individuals.

Similarly, although several studies have shown the association between OSA and clinical CVD, there were potential moderators such as sex to confound the relationship. In the sleep heart health study, there was a significant association between OSA and ischemic stroke in men, but not in women [76]. In another longitudinal study, Gottlieb et al. uncovered that OSA was significantly associated with incident coronary heart disease in men younger than 70 years of age (hazard ratio (HR): 1.10, 95% CI: 1.00-1.21, per 10-unit increase in AHI) but not in older men or in women of any age [77]. The study also found a significant association between OSA and incident heart failure in men but not in women (HR: 1.13, 95% CI: 1.02-1.26, per 10-unit increase in AHI).

A meta-analysis of several prospective studies showed that OSA is associated with stroke in men (OR: 2.24, 95% CI: 1.57-3.19) and an increase of 10 units in AHI is associated with a greater odds of cerebrovascular events (OR: 1.36, 95% CI: 1.26-1.43) [77]. The meta-analysis pointed that OSA was significantly associated with ischemic heart disease in studies predominately. comprised of male participants (OR: 1.92, 95% CI: 1.06-3.48), but not in a female-specific study (OR: 0.4, 95% CI: 0.12-1.30). Without considering sex difference, the link between OSA and ischemic heart disease was not significant. Although the heterogeneity of included malepredominant studies was remarkable (I2=70%). In brief, existing evidence may support OSA as a strong risk factor of cardiovascular and cerebrovascular diseases in men, while not in women, partially explained by small female samples [78]. A recent controlled trial also showed men have lower ejection fraction and more implanted stents than women in patients with OSA and acute coronary syndrome [79]. Roca et al. reported OSA was associated with highsensitivity troponin T, a powerful risk factor of heart failure, in women but not in men (p=0.03 vs. p=0.94) and with incident heart failure or death in the similar pattern (women vs. men, p=0.01 vs p=0.1) [80]. Another study found that moderate to severe OSA was associated with the presence of coronary artery calcium, an indicator of atherosclerosis or coronary artery disease, in perimenopausal or menopausal women (OR: 8.19, 95%CI: 1.66-40.32) [81]. Sex hormones may play a role in male-to-female differences. In summary, men with OSA were likely to have greater risk of stroke and ischemic heart disease than those without OSA and this is consistent with the finding in animal study that the oxidative stress induced by intermittent hypoxia affected less vascular injury in females than males [82-84]. However, the sex difference in heart failure risk in OSA patients was inconsistent between studies.

Conclusion

In our brief review, there were substantial evidence for the relationship between nocturnal hypoxemia and renal microvascular injury, but the association of OSA severity defined by AHI with microvascular disease in target organs, i.e. kidney, heart, brain and retina is controversial. Sex may moderate the OSA association with microvascular dysfunction in each site and mediate the OSA effect on clinical CVD. Further studies are needed to investigate not only crosssectional but also temporal association of OSA evaluated by AHI and the hypoxemia index with multiple microvascular characteristics and clinical CVD in men and women.

Financial support

None.

References

1. Carney PR, Berry RB, Geyer JD. Clinical sleep disorders, xv(1) 505, Philadelphia: Lippincott Williams & Wilkins (2005).
2. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am. J. Respir. Crit. Care. Med 165(9), 1217-1239 (2002).
3. Sanchez-de-la-Torre MF, Campos-Rodriguez, Barbe F. Obstructive sleep apnoea and cardiovascular disease. Lancet. Respir. Med 1(1), 61-72 (2013).
4. Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am. J. Epidemiol 177(9), 1006-1014 (2013).
5. Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am. J. Respir. Crit. Care. Med 177(4), 369-375 (2008).
6. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep. Med. Rev 7(1), 35-51 (2003).
7. Henderson LA, Macefield VG. Obstructive Sleep Apnoea and Hypertension: the Role of the Central Nervous System. Curr. Hypertens. Rep 18(7), 59 (2016).
8. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest 96(4), 1897-1904 (1995).
9. Hering D, Lachowska K, Schlaich M. Role of the Sympathetic Nervous System in Stress-Mediated Cardiovascular Disease. Curr. Hypertens. Rep 17(10), 80 (2015).
10. Gimbrone MA, Garcia-Cardena G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ. Res 118(4), 620-636 (2016).
11. Yamauchi M, Tamaki S, Tomoda K, et al. Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep. Breath 10(4), 189-193 (2006).
12. Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat. Rev. Cardiol. 7(12), 677-685 (2010).
13. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am. J. Respir. Crit. Care. Med 165(7), 934-939 (2002).
14. Jelic S, Padeletti M, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117(17), 2270-2278 (2008).
15. Kanbay A,  Ceylan E, İnönü Köseoğlu H, et al. Endocan: A Novel Predictor of Endothelial Dysfunction in Obstructive Sleep Apnea Syndrome. Clin. Respir. J (2016).
16. Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension 58(5),  811-817 (2011).
17. Aronsohn RS, Whitmore H, Van Cauter E, et al. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am. J. Respir. Crit. Care. Med 181(5), 507-513 (2010).
18. Liew G, Wang JJ, Mitchell P, et al. Retinal vascular imaging: a new tool in microvascular disease research. Circ. Cardiovasc. Imaging 1(2), 156-161 (2008).
19. Cheung N, Sharrett AR, Klein R, et al. Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis. Hypertension 50(4), 617-622 (2007).
20. Nguyen TT, Wang JJ, Wong TY. Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications. Diabetes. Care 30(10), 2708-2715 (2007).
21. Myers CE, Klein R, Knudtson MD, et al. Determinants of retinal venular diameter: the Beaver Dam Eye Study. Ophthalmology 119(12), 2563-2571 (2012).
22. Tsioufis C, Thomopoulos C, Dimitriadis K, et al. Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. Am. J. Kidney. Dis 52(2), 285-293 (2008).
23. Agrawal V, Vanhecke TE, Rai B, et al. Albuminuria and renal function in obese adults evaluated for obstructive sleep apnea. Nephron. Clin. Pract 113(3), c140-147 (2009).
24. Canales MT, Paudel ML, Taylor BC, et al. Sleep-disordered breathing and urinary albumin excretion in older men. Sleep. Breath 15(1), 137-144 (2011).
25. Furukawa, S., et al., Nocturnal intermittent hypoxia as an associated risk factor for microalbuminuria in Japanese patients with type 2 diabetes mellitus. Eur J Endocrinol, 2013. 169(2): p. 239-46.
26. Bulcun E, Ekici M, Ekici A, et al. Microalbuminuria in obstructive sleep apnea syndrome. Sleep. Breath 19(4), 1191-1197 (2015).
27. Chen Y, Li Y, Jiang Q, et al. Analysis of Early Kidney Injury-Related Factors in Patients with Hypertension and Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS). Arch. Iran. Med 18(12), 827-833 (2015).
28. Ting H, Liou CM, Shih TS, et al. Obstructive sleep apnea rather than diabetes or obesity associated with proteinuria in late mid-aged male workers: a decision tree analysis. Sleep. Breath 19(4), 1167-1174 (2015).
29. Zhang R, Zhang P, Zhao F, et al. Association of Diabetic Microvascular Complications and Parameters of Obstructive Sleep Apnea in Patients with Type 2 Diabetes. Diabetes. Technol. Ther 18(7), 415-420 (2016).
30. Davies CW, Crosby JH, Mullins RL, et al. Case control study of cerebrovascular damage defined by magnetic resonance imaging in patients with OSA and normal matched control subjects. Sleep 24(6), 715-720 (2001).
31. Harbison J, Gibson GJ, Birchall D, et al. White matter disease and sleep-disordered breathing after acute stroke. Neurology 61(7), 959-963 (2003).
32. Ding J, Nieto FJ, Beauchamp NJ Jr, et al. Sleep-disordered breathing and white matter disease in the brainstem in older adults. Sleep 27(3), 474-479 (2004).
33. Eguchi K, Kario K, Hoshide S, et al. Nocturnal hypoxia is associated with silent cerebrovascular disease in a high-risk Japanese community-dwelling population. Am. J. Hypertens 18(11), 1489-1495 (2005).
34. Robbins J, Redline S, Ervin A, et al. Associations of sleep-disordered breathing and cerebral changes on MRI. J. Clin. Sleep. Med 1(2), 159-165 (2005).
35. Nishibayashi M, Miyamoto M, Miyamoto T, et al. Correlation between severity of obstructive sleep apnea and prevalence of silent cerebrovascular lesions. J. Clin. Sleep. Med 4(3), 242-247 (2008).
36. Kiernan TE, Capampangan DJ, Hickey MG, et al. Sleep apnea and white matter disease in hypertensive patients: a case series. Neurologist 17(5), 289-291 (2011).
37. Kim H, Yun CH, Thomas RJ, et al. Obstructive sleep apnea as a risk factor for cerebral white matter change in a middle-aged and older general population. Sleep 36(5), 709-715B (2013).
38. Kepplinger J, Barlinn K, Boehme AK, et al. Association of sleep apnea with clinically silent microvascular brain tissue changes in acute cerebral ischemia. J. Neurol 261(2), 343-349 (2014).
39. Rossmanith WG, Wolfahrt S, Ecker A, et al. The demonstration of progesterone, but not of estrogen, receptors in the developing human placenta. Horm. Metab. Res 29(12), 604-610 (1997).
40. Orea-Tejeda A, Valencia-Flores M, Castillo-Martinez L, et al. Abnormal SPECT myocardial perfusion imaging during periods of obstructive sleep apnea in morbid obese patients without known heart disease. Rev. Invest. Clin 55(1), 18-25 (2003).
41. Butt M, Khair OA, Dwivedi G, et al. Myocardial perfusion by myocardial contrast echocardiography and endothelial dysfunction in obstructive sleep apnea. Hypertension 58(3), 417-424 (2011).
42. Nakashima H, Muto S, Amenomori K, et al. Impact of obstructive sleep apnea on myocardial tissue perfusion in patients with ST-segment elevation myocardial infarction. Circ. J 75(4), 890-896 (2011).
43. Lee CH, Khoo SM, Tai BC, et al. Obstructive sleep apnea in patients admitted for acute myocardial infarction. Prevalence, predictors, and effect on microvascular perfusion. Chest 135(6), 1488-1495 (2009).
44. Schwartz RS, Burke A, Farb A, et al. Microemboli and microvascular obstruction in acute coronary thrombosis and sudden coronary death: relation to epicardial plaque histopathology. J. Am. Coll. Cardiol 54(23), 2167-2173 (2009).
45. Goto I, Katsuki S, Ikui H, et al. Pathological studies on the intracerebral and retinal arteries in cerebrovascular and noncerebrovascular diseases. Stroke 6(3), 263-269 (1975).
46. Wong TY, Klein R, Klein BE, et al. Retinal microvascular abnormalities and their relationship with hypertension, cardiovascular disease, and mortality. Surv. Ophthalmol 46(1), 59-80 (2001).
47. Cheung CY, Chen C, Wong TY. Ocular Fundus Photography as a Tool to Study Stroke and Dementia. Semin. Neurol 35(5), 481-490 (2015).
48. Boland LL, Shahar E, Wong TY, et al. Sleep-disordered breathing is not associated with the presence of retinal microvascular abnormalities: the Sleep Heart Health Study. Sleep 27(3), 467-473 (2004).
49. Ikram MK, de Jong FJ, Vingerling JR, et al. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest. Ophthalmol. Vis. Sci 45(7), 2129-2134 (2004).
50. Wong TY, Islam FM, Klein R, et al. Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest. Ophthalmol. Vis. Sci 47(6), 2341-2350 (2006).
51. Wong TY, Duncan BB, Golden SH, et al. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest. Ophthalmol. Vis. Sci 45(9), 2949-2954 (2004).
52. Shankar A, Peppard PE, Young T, et al. Sleep-disordered breathing and retinal microvascular diameter. Atherosclerosis 226(1), 124-128 (2013).
53. Stoohs RA, Facchini F, Guilleminault C. Insulin resistance and sleep-disordered breathing in healthy humans. Am. J. Respir. Crit. Care. Med 154(1), 170-174 (1996).
54. Gami AS, Somers VK. Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur. Heart. J 25(9), 709-711 (2004).
55. Lam JC, Lam B, Lam CL, et al. Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong. Respir. Med 100(6), 980-987 (2006).
56. Shaw JE, Punjabi NM, Wilding JP, et al. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes. Res. Clin. Pract 81(1), 2-12 (2008).
57. Elmasry A, Janson C, Lindberg E, et al. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J. Intern. Med 248(1), 13-20 (2000).
58. Resnick HE, Redline S, Shahar E, et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes. Care 26(3), 702-709 (2003).
59. Einhorn D, Stewart DA, Erman MK, et al. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr. Pract 13(4), 355-362 (2007).
60. Foster GD, Sanders MH, Millman R, et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes. Care 32(6), 1017-1019 (2009).
61. Peled N, Kassirer M, Shitrit D, et al. The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir. Med 101(8), 1696-701 (2007).
62. Ryan S, McNicholas WT. Inflammatory cardiovascular risk markers in obstructive sleep apnoea syndrome. Cardiovasc. Hematol. Agents. Med. Chem 7(1), 76-81 (2009).
63. Nadeem R, Molnar J, Madbouly EM, et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J. Clin. Sleep. Med 9(10), 1003-10012 (2013).
64. Seetho IW, Wilding JP. Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome. Chron. Respir. Dis 11(4), 257-275 (2014).
65. Kosseifi S, Bailey B, Price R, et al. The association between obstructive sleep apnea syndrome and microvascular complications in well-controlled diabetic patients. Mil. Med 175(11), 913-916 (2010).
66. West SD, Groves DC, Lipinski HJ, et al. The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea. Diabet. Med 27(4), 423-430 (2010).
67. Rudrappa S, Warren G, Idris I. Obstructive sleep apnoea is associated with the development and progression of diabetic retinopathy, independent of conventional risk factors and novel biomarkers for diabetic retinopathy. Br. J. Ophthalmol 96(12), 1535 (2012).
68. Banerjee D, Leong WB, Aroraet T, et al. The potential association between obstructive sleep apnea and diabetic retinopathy in severe obesity-the role of hypoxemia. PLoS. One 8(11), pe79521 (2013).
69. Nishimura A, Kasai T, Tamura H, et al. Relationship between sleep disordered breathing and diabetic retinopathy: Analysis of 136 patients with diabetes. Diabetes. Res. Clin. Pract 109(2), 306-311 (2015).
70. Quintana-Gallego E, Carmona-Bernal C, Capote F, et al. Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients. Respir. Med 98(10), 984-989 (2004).
71. Vagiakis E, Kapsimalis F, Lagogianni I, et al. Gender differences on polysomnographic findings in Greek subjects with obstructive sleep apnea syndrome. Sleep. Med 7(5), 424-430 (200).
72. Lin CM, Davidson TM, Ancoli-Israel S. Gender differences in obstructive sleep apnea and treatment implications. Sleep. Med. Rev 12(6), 481-496 (2008).
73. Chew M, Xie J, Klein R, et al. Sleep apnea and retinal signs in cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Sleep. Breath 20(1), 15-23 (2016).
74. Lin GM, Redline S, Klein R, et al. Sex-Specific Association of Obstructive Sleep Apnea With Retinal Microvascular Signs: The Multi-Ethnic Study of Atherosclerosis. J. Am. Heart. Assoc 5(7) (2016).
75. Lin GM, Colangelo LA, Lloyd-Jones DM, et al. Association of Sleep Apnea and Snoring With Incident Atrial Fibrillation in the Multi-Ethnic Study of Atherosclerosis. Am. J. Epidemiol 182(1), 49-57 (2015).
76. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am. J. Respir. Crit. Care. Med 182(2), 269-277 (2010).
77. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 122(4), 352-360 (2010).
78. Loke YK, Brown JW, Kwok CS, et al. Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysis. Circ. Cardiovasc. Qual. Outcomes 5(5), 720-728 (2012).
79. Sanchez-de-la-Torre A, Abad J, Durán-Cantolla J, et al. Effect of Patient Sex on the Severity of Coronary Artery Disease in Patients with Newly Diagnosis of Obstructive Sleep Apnoea Admitted by an Acute Coronary Syndrome. PLoS. One 11(7), pe0159207 (2016).
80. Roca GQ, Redline S, Claggett B, et al. Sex-Specific Association of Sleep Apnea Severity With Subclinical Myocardial Injury, Ventricular Hypertrophy, and Heart Failure Risk in a Community-Dwelling Cohort: The Atherosclerosis Risk in Communities-Sleep Heart Health Study. Circulation 132(14), 1329-1337 (2015).
81. Medeiros AK, Coutinho RQ, Barros IM, et al. Obstructive sleep apnea is independently associated with subclinical coronary atherosclerosis among middle-aged women. Sleep. Breath (2016).
82. Tamas A, Lubics A , Szalontay L, et al. Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats. Behav. Brain. Res 158(2), 221-229 (2005).
83. Li QY, Li M, Feng Y, et al. Chronic intermittent hypoxia induces thioredoxin system changes in a gender-specific fashion in mice. Am. J. Med. Sci 343(6), 458-461 (2012).
84. Li QY, Feng Y, Lin YN, et al. Gender difference in protein expression of vascular wall in mice exposed to chronic intermittent hypoxia: a preliminary study. Genet. Mol. Res13(4), 8489-8501 (2014).